Literature DB >> 12674693

Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV.

Robert O Koch1, Ivo W Graziadei, Robert Zangerle, Nikolaus Romani, Hans Maier, Wolfgang Vogel.   

Abstract

Severe hepatotoxicity is a rare but potentially life-threatening side effect of antiretroviral therapy. In this case report we describe an HIV-positive patient who was admitted to our clinic with evidence of severe acute pancreatitis 18 months after the introduction of antiretroviral treatment, which included stavudine and didanosine. Shortly afterwards, she developed lactate acidosis and acute hepatic failure associated with renal failure. Renal support (hemofiltration) was required for three days. The patient subsequently developed grade III encephalopathy, as well as a large pleural effusion and ascites. Although the reported outcome of patients with liver failure due to antiretroviral treatment is poor, with a high mortality rate, our patient fully recovered after intensive supportive care and cessation of the antiretroviral agents. Liver biopsy revealed microvesicular steatosis and giant mitochondria, which are the typical hallmarks of mitochondrial damage, the presumed mechanism of antiretroviral drug toxicity. More than three years later the patient has an excellent clinical status with a stable HIV infection and no need for antiretroviral treatment. This case report indicates the need for increased awareness of the potential hepatotoxicity of an antiretroviral therapy, as severe side effects may occur more frequently with increasing use of such treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12674693     DOI: 10.1007/BF03040295

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  31 in total

Review 1.  Antiretroviral drug toxicity -- a challenge for the hepatologist?

Authors:  Ulrich Spengler; Mathias Lichterfeld; Jürgen Kurt Rockstroh
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

Review 2.  The role of stavudine in the management of adults with HIV infection.

Authors:  G J Moyle; B G Gazzard
Journal:  Antivir Ther       Date:  1997-12

3.  Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts.

Authors:  W Lewis; E S Levine; B Griniuviene; K O Tankersley; J M Colacino; J P Sommadossi; K A Watanabe; F W Perrino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

4.  Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases.

Authors:  Sarah J Clark; Sarah Creighton; Bernard Portmann; Christopher Taylor; Julia A Wendon; Matthew E Cramp
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

Review 5.  Antiretroviral drugs for AIDS.

Authors:  J J Lipsky
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

Review 6.  Transplantation in the HIV+ patient.

Authors:  P C Kuo; P G Stock
Journal:  Am J Transplant       Date:  2001-05       Impact factor: 8.086

7.  Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy.

Authors:  F Bissuel; F Bruneel; F Habersetzer; D Chassard; L Cotte; M Chevallier; J Bernuau; J C Lucet; C Trepo
Journal:  J Intern Med       Date:  1994-04       Impact factor: 8.989

8.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.

Authors:  C H Chen; M Vazquez-Padua; Y C Cheng
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

9.  Hepatic toxicity associated with 2'-3' dideoxyinosine in children with AIDS.

Authors:  F Lacaille; M B Ortigao; M Debré; C Rouzioux; N Brousse; S Blanche
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-04       Impact factor: 2.839

10.  High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection.

Authors:  D Havlir; S H Cheeseman; M McLaughlin; R Murphy; A Erice; S A Spector; T C Greenough; J L Sullivan; D Hall; M Myers
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

View more
  6 in total

1.  Drug-Induced Liver Injury in HIV Patients.

Authors:  Guy W Neff; Dushyantha Jayaweera; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

Review 2.  Acute liver failure.

Authors:  Ludwig Kramer
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

3.  Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).

Authors:  Ludwig Kramer; Edith Bauer; Peter Schenk; Rudolf Steininger; Marion Vigl; Reinhold Mallek
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

4.  Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.

Authors:  Janez Tomazic; Katja Ul; Gabriele Volcansek; Samo Gorensek; Misa Pfeifer; Primoz Karner; Janez Prezelj; Gaj Vidmar; Ludvik Vidmar
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 5.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21

6.  A case report of nifedipine-induced hepatitis with jaundice.

Authors:  Dimas Yusuf; Joanna Christy; David Owen; Meghan Ho; David Li; Martin J Fishman
Journal:  BMC Res Notes       Date:  2018-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.